Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Qingqiao Zhike Decoction is a Traditional Chinese Medicine (TCM) herbal formulation developed by Professor Gao Feng at Wangjing Hospital, China Academy of Chinese Medical Sciences. It is primarily utilized for the treatment of chronic cough, specifically targeting cases associated with Upper Airway Cough Syndrome (UACS) or "wind-induced" cough. The decoction is designed to "clear the orifices" (referring to the nasal and pharyngeal passages) and suppress the cough reflex. It is often evaluated in clinical settings alongside other specialized TCM regimens such as Zhisou Guomin Decoction and Beimu Zhizhu Decoction to compare their efficacy against standard conventional drug therapies. The formulation follows the TCM principle of combining disease differentiation with syndrome differentiation to provide personalized treatment for respiratory conditions.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on qingqiao zhike decoction.